Julie Morgan

Specifically, the agency said the study's comparison group did not reflect the best available standard of care in the U.S.

at the time the trial was conducted.

Moderna said the FDA did not raise any specific concerns about the vaccine's safety or effectiveness.

The company also said the decision was inconsistent with earlier written feedback it had received from the agency.

Moderna has requested a meeting with the FDA officials to clarify its next steps.

Despite the setback, Moderna said it does not expect the decision to affect its 2026 financial guidance.

Estee Lauder is suing Walmart for selling counterfeit versions of its licensed products.

The cosmetics company claims third parties on Walmart's website were selling counterfeit versions of La Mer, Clinique, Aveda, and Tom Ford products.

And although Walmart did not sell the products directly, Estee Lauder's lawsuit accuses the company of facilitating these sales.

calling Walmart's conduct extreme, outrageous, fraudulent, and harmful.

The complaint further alleges that Walmart allowed Estee Lauder trademarks to be used in the search engine, enabling Walmart to profit from these sales.

According to an investigation by CNBC, Walmart did not sufficiently vet third-party sellers and the products they offered to prevent counterfeit items from being sold on its online marketplace.

Estee Lauder is demanding the defendants in its lawsuit be ordered to stop selling products that bear the company's trademarks, monetary damages, and compensation for legal fees.

It's that time to tell you about a few other articles that are trending.

OpenAI, Samsung, and SK Telecom will reportedly start setting up data centers in Korea next month.

Activist investor Ancora is set to oppose the Warner Bros.

deal with Netflix.

And XAI loses another co-founder.

Now for a check of the Catalyst watch.

FedEx will hold an Investor Day event to lay out multi-year strategy and financial targets.